- Report
- January 2024
- 200 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2023
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2023
- 250 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2023
- 250 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- June 2021
Global
From €2616EUR$2,800USD£2,213GBP
€3737EUR$4,000USD£3,161GBP
- Report
- March 2024
- 163 Pages
Global
From €2336EUR$2,500USD£1,976GBP
From €2336EUR$2,500USD£1,976GBP
- Report
- April 2022
- 120 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- October 2021
- 120 Pages
Global
From €2336EUR$2,500USD£1,976GBP
From €3270EUR$3,500USD£2,766GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3270EUR$3,500USD£2,766GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3270EUR$3,500USD£2,766GBP
From €3270EUR$3,500USD£2,766GBP
- Report
- September 2024
- 82 Pages
Japan
From €3270EUR$3,500USD£2,766GBP
- Report
- February 2024
- 175 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- February 2024
- 172 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- November 2023
- 190 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- November 2023
- 78 Pages
France
From €3270EUR$3,500USD£2,766GBP
- Report
- November 2023
- 178 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- November 2023
- 190 Pages
Global
From €4204EUR$4,500USD£3,556GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more